TORONTO, July 3, 2024
/CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the
"Trust") announces that it will hold a conference call to discuss
its second quarter 2024 financial results on Wednesday, August 7, 2024, at 8:00 a.m. ET. The Trust will report its financial
results on Tuesday, August 6, 2024,
after market close.
All interested parties may join the conference call by dialling
416-764-8659 or 1-888-664-6392 approximately 15 minutes prior to
the call to secure a line. You will be put on hold until the
conference call begins. To join the conference call without
operator assistance, you may register and enter your phone number
at https://emportal.ink/3zk9Ebc to receive an instant automated
callback. A question-and-answer session will follow management's
prepared remarks, at which time the operator will provide
instructions for qualified equity analysts to submit questions.
A live webcast of the conference call, including a slide
presentation, will be available at
https://app.webinar.net/MAxX169nQNb. Please connect at least 15
minutes prior to the conference call to ensure adequate time for
any software download that may be required to join the webcast. The
webcast will be archived on the Trust's website following the call
date.
About DRI Healthcare Trust
DRI Healthcare Trust is managed by DRI Capital Inc. ("DRI
Healthcare"), the pioneer in global pharmaceutical royalty
monetization with a 35-year history of accelerating innovation by
providing capital to inventors, academic institutions and biopharma
companies. Since its founding in 1989, DRI Healthcare has deployed
more than US$3.0 billion, acquiring
more than 70 royalties on 45-plus drugs, including Eylea, Keytruda,
Orserdu, Spinraza, Stelara, Vonjo, Zejula and Zytiga. DRI
Healthcare Trust's units are listed and trade on the Toronto Stock
Exchange in Canadian dollars under the symbol "DHT.UN" and in U.S.
dollars under the symbol "DHT.U". To learn more, visit
drihealthcare.com or follow us on LinkedIn.
SOURCE DRI Healthcare Trust